|
 |
Study Group Launched to Prevent Alzheimer's Catastrophe
(Source: HealthBeat) - Speakers on Capitol Hill warned that Medicare outlays to treat Alzheimer's will grow, within two decades, to $400 billion a year.
Alzhemed in Trouble
(Source: SeekingAlpha) - Since April, Neurochem has been working on a statistical model for the Phase III clinical trial of its Alzheimer's drug, Alzhemed. Another delay recently for more adjustments to this model does not bode well for the pharmaceutical company.
Violence in Nursing Homes an Understudied Threat
(Source: Reuters) - While the traditional view of elder abuse in nursing homes involves staff harming residents, new research suggests residents may have more to fear from their peers.
|
|